MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20133037

October 25, 2022

国药准字H20133037

Drug Information

瑞格列奈片

万生

片剂

1.0mg

化学药品

October 25, 2022

Company Information

Applicant Company

北京市通州区通州工业开发区广源东街8号

Manufacturing Company

北京市通州区通州工业开发区广源东街8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath